Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
Retina Vitreous Associates Medical Group · University of Ulsan · +7 more institutions
Indexed incrossrefpubmed
Abstract
Design
Two randomized, multicenter, masked, sham-controlled, phase III clinical trials with identical protocols were conducted. Data were pooled for analysis.
Participants
Patients (n = 1048) with DME, best-corrected visual acuity (BCVA) of 20/50 to 20/200 Snellen equivalent, and central retinal thickness (CRT) of ≥300 μm by optical coherence tomography.
Citation impact
1,106
total citations
- FWCI
- 88.61
- Percentile
- 100%
- References
- 33
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Medicine
- Implant
- Dexamethasone
- Clinical endpoint
- Randomized controlled trial
- Visual acuity
- Intraocular pressure
- Adverse effect
No related works found for this paper.